Symbion, Inc., a leading player in the healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in 2004, the company has established itself as a trusted provider of innovative healthcare solutions, focusing on supply chain management and operational efficiency for healthcare facilities. Symbion's core offerings include comprehensive procurement services, inventory management, and consulting solutions tailored to enhance the performance of healthcare organisations. What sets Symbion apart is its commitment to leveraging technology and data analytics to optimise supply chain processes, ensuring that clients receive the highest quality products at competitive prices. With a strong market position, Symbion has achieved notable milestones, including partnerships with numerous healthcare providers and recognition for its contributions to improving operational efficiencies in the sector. The company continues to drive advancements in healthcare supply chain management, making it a vital resource for healthcare professionals.
How does Symbion, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Symbion, Inc.'s score of 20 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Symbion, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Surgery Partners, Inc., which may influence its climate-related initiatives and reporting practices. As of now, Symbion, Inc. has not established any documented reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of specific targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data and reduction initiatives, it is essential for Symbion, Inc. to consider setting measurable climate commitments in line with industry standards to enhance its sustainability profile and contribute to broader climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Symbion, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.